Ticagrelor Versus Prasugrel in Acute Coronary Syndrome: Real-World Treatment and Safety

Ticagrelor Versus Prasugrel in Acute Coronary Syndrome: Real-World Treatment and Safety

<b>Introduction</b>: A direct head-to-head comparison between potent P2Y12 inhibitors: prasugrel versus ticagrelor is still lacking. <b>Purpose</b>: In this single-center study, we sought to address the efficacy and safety of these two third-generation antiplatelet drugs, aft...

Full description

Saved in:
Bibliographic Details
Main Authors: Fadel Bahouth, Boris Chutko, Haitham Sholy, Sabreen Hassanain, Gassan Zaid, Evgeny Radzishevsky, Ibrahem Fahmwai, Mahmod Hamoud, Nemer Samnia, Johad Khoury, Idit Dobrecky-Mery
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Medicines
Subjects:
acute coronary syndrome
ticagrelor
prasugrel
dual anti platelet drugs
Online Access:https://www.mdpi.com/2305-6320/12/2/13
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.mdpi.com/2305-6320/12/2/13

Similar Items